Clinical Trial Update: Tipifarnib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]

View source ↗

Summary

This Phase 1 trial update reports on the combination of tipifarnib, radiation therapy, and temozolomide in adults with newly diagnosed glioblastoma multiforme, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Glioblastoma
• Glioblastoma Multiforme
• Gliosarcoma

Drugs mentioned

• Temozolomide (Temozolomide)
• Tipifarnib (tipifarnib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Giant Cell Glioblastoma, Adult Glioblastoma | Phase 1 | Status: COMPLETED